Brentuximab Vedotin for Previously Untreated Peripheral T-cell Lymphpoma (ECHELON-2 trial) - New Standard of Care & Mantle Cell Lymphoma - Treatment and Review of Current Trials

06/2019

0 Comments
Login to view comments. Click here to Login